SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001313799-05-000003
Filing Date
2005-02-15
Accepted
2005-02-15 16:09:12
Documents
1
Period of Report
2005-02-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 2771
  Complete submission text file 0001313799-05-000003.txt   4596
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address RUBEN DARIO #223 5-A CHAPULTEPEC MORALES MEXICO D.F. O5 11570
Business Address 52554334556
Gonzalez Alejandro (Reporting) CIK: 0001313799 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-24274 | Film No.: 05617292